Inaccurate diagnosis of HIV-1 group M and O is a key challenge for ongoing universal access to antiretroviral treatment and HIV prevention in Cameroon AF Aghokeng, E Mpoudi-Ngole, H Dimodi, A Atem-Tambe, M Tongo, ... PLoS One 4 (11), e7702, 2009 | 117 | 2009 |
Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open … A Calmy, TT Sanchez, C Kouanfack, M Mpoudi-Etame, S Leroy, ... The lancet HIV 7 (10), e677-e687, 2020 | 114 | 2020 |
HIV infection in rural villages of Cameroon P Nyambi, L Zekeng, H Kenfack, M Tongo, A Nanfack, I Nkombe, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 31 (5), 506-513, 2002 | 58 | 2002 |
HIV type 1 group M clades infecting subjects from rural villages in equatorial rain forests of Cameroon P Zhong, S Burda, M Urbanski, H Kenfack, M Tongo, L Heyndrickx, ... JAIDS-HAGERSTOWN MD- 31 (5), 495-505, 2002 | 54 | 2002 |
High degree of HIV-1 group M (HIV-1M) genetic diversity within circulating recombinant forms: insight into the early events of HIV-1M evolution M Tongo, JR Dorfman, DP Martin Journal of virology 90 (5), 2221-2229, 2016 | 39 | 2016 |
Characterization of HIV-1 gag and nef in Cameroon: further evidence of extreme diversity at the origin of the HIV-1 group M epidemic M Tongo, DP Martin, L Zembe, E Mpoudi-Ngole, C Williamson, ... Virology journal 10, 1-7, 2013 | 29 | 2013 |
Challenges in the design of a T cell vaccine in the context of HIV-1 diversity M Tongo, WA Burgers Viruses 6 (10), 3968-3990, 2014 | 23 | 2014 |
Rapid increase of community SARS-CoV-2 seroprevalence during second wave of COVID-19, Yaoundé, Cameroon FA Ndongo, E Guichet, ED Mimbé, J Ndié, R Pelloquin, M Varloteaux, ... Emerging Infectious Diseases 28 (6), 1233, 2022 | 21 | 2022 |
Unravelling the complicated evolutionary and dissemination history of HIV-1M subtype A lineages M Tongo, GW Harkins, JR Dorfman, E Billings, S Tovanabutra, ... Virus Evolution 4 (1), vey003, 2018 | 17 | 2018 |
Near full-length HIV type 1M genomic sequences from Cameroon: Evidence of early diverging under-sampled lineages in the country M Tongo, JR Dorfman, MR Abrahams, E Mpoudi-Ngole, WA Burgers, ... Evolution, medicine, and public health 2015 (1), 254-265, 2015 | 16 | 2015 |
Immune correlates of disease progression in linked HIV-1 infection M Tuen, JS Bimela, AN Banin, S Ding, GW Harkins, S Weiss, V Itri, ... Frontiers in immunology 10, 1062, 2019 | 13 | 2019 |
Refined identification of neutralization-resistant HIV-1 CRF02_AG viruses RA Jacob, F Abrahams, M Tongo, M Schomaker, P Roux, E Mpoudi Ngole, ... Journal of virology 86 (14), 7699-7703, 2012 | 13 | 2012 |
Neutralizing antibody patterns and viral escape in HIV-1 non-B subtype chronically infected treatment-naive individuals HR Kelly, M Urbanski, S Burda, P Zhong, F Konings, J Nanfack, M Tongo, ... Human antibodies 14 (3-4), 89-99, 2005 | 13 | 2005 |
Development of a versatile, near full genome amplification and sequencing approach for a broad variety of HIV-1 group M variants AN Banin, M Tuen, JS Bimela, M Tongo, P Zappile, ... Viruses 11 (4), 317, 2019 | 12 | 2019 |
Susceptibility to transmitting HIV in patients initiating antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER Trial) G Ndziessi, J Cohen, C Kouanfack, F Marcellin, MP Carierri, ... PloS one 8 (4), e62611, 2013 | 11 | 2013 |
Prediction of HIV drug resistance based on virologic, immunologic, clinical, and/or adherence criteria in the stratall ANRS 12110/ESTHER trial in Cameroon C Boullé, C Kouanfack, G Laborde-Balen, AF Aghokeng, S Boyer, ... Clinical infectious diseases 57 (4), 604-607, 2013 | 10 | 2013 |
Phylogenetics of HIV-1 subtype G env: Greater complexity and older origins than previously reported M Tongo, RG Essomba, F Nindo, F Abrahams, AJ Nanfack, J Fokam, ... Infection, Genetics and Evolution 35, 9-18, 2015 | 8 | 2015 |
An epidemiological synthesis of emerging and re-emerging zoonotic disease threats in Cameroon, 2000–2022: A systematic review NB Tahmo, FS Wirsiy, DB Nnamdi, M Tongo, JV Lawler, MJ Broadhurst, ... IJID regions 7, 84-109, 2023 | 6 | 2023 |
Near full genome characterization of HIV‐1 unique recombinant forms in Cameroon reveals dominant CRF02_AG and F2 recombination patterns AN Banin, M Tuen, JS Bimela, M Tongo, P Zappile, ... African Journal of Reproduction and Gynaecological Endoscopy 22 (7), 2019 | 6 | 2019 |
Subtype-specific differences in Gag-protease replication capacity of HIV-1 isolates from East and West Africa O Farinre, K Gounder, T Reddy, M Tongo, J Hare, B Chaplin, J Gilmour, ... Retrovirology 18 (1), 11, 2021 | 5 | 2021 |